Yuanbao Inc ADR Dossier - Source-backed chat

Yuanbao Inc ADR

YBNASDAQ

SectorFinancials

IndustryInsurance Brokers

Beta (adjusted)0.65

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $12.44Price as of 30 Sep 2026

Data confidence Sign in to view data confidence

Market Cap $573.2M

Enterprise Value −$287.2M

Shares Outstanding 46.1M diluted

Next Earnings Date9 Dec 2026

Last ex-dividend2 Jul 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Yuanbao Inc. (NASDAQ: YB) is a highly efficient, technology-driven online insurance distributor in China that operates a scalable, asset-light business model. By leveraging advanced AI models and big data, the company connects insurance carriers with consumers without bearing underwriting risks. Yuanbao's Q1 2026 results demonstrate robust top-line growth (+35.6% YoY) and strong profitability with a 29.5% net margin, backed by a fortress balance sheet with RMB 4.74 billion in cash and short-term investments. Despite its high growth and profitability, the stock trades at a very low earnings multiple, presenting a compelling growth-at-a-reasonable-price (GARP) opportunity.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets1 analysts · as of 18 Aug 2026

Low · most bearish analyst$17.94

Mean target$17.94

High · most bullish analyst$17.94

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$12.01

Intensifying competition in the Chinese insurtech space and stricter regulatory crackdowns on online financial marketing increase customer acquisition costs. This compresses net margins and slows down revenue growth, keeping the stock's valuation depressed.

Base CaseCentral scenario

$18.50

Yuanbao maintains steady double-digit revenue growth of 25-30% YoY, supported by its leading position in China's online life and health insurance distribution market. The company continues to generate strong operating cash flows, successfully executes its US$15 million share buyback program, and distributes its annual cash dividend of US$1.26 per ADS, leading to a gradual valuation recovery.

Bull CaseUpside scenario

$21.80

Rapid scaling of the high-margin system services segment, deeper integration of organizational AI across the entire insurance lifecycle, and successful expansion of the partner carrier network drive significant operating leverage. This leads to substantial margin expansion and robust free cash flow generation, prompting a major upward re-rating of the stock.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Asset-light business model with zero underwriting risk, collecting stable commission and system service fees.
Strong financial profile with 35.6% YoY revenue growth and a high net income margin of 29.5% in Q1 2026.
Fortress balance sheet with RMB 4.74 billion in cash, cash equivalents, and deposits, representing a significant portion of its market capitalization.
Deep integration of proprietary AI models optimizing personalized recommendations, underwriting, and claims processing.
Active capital return program including an annual cash dividend of US$1.26 per ADS and a US$15 million share repurchase authorization.

Key Investment Risks

Regulatory uncertainty surrounding online financial marketing and data privacy regulations in China.
High reliance on continuous marketing spend to acquire new users, which could face rising costs due to competition.
Potential volatility in the Chinese insurance market affecting consumer demand for life and health insurance products.

Thesis Invalidation Triggers

A material regulatory ban or severe restriction on online insurance brokerage operations in China.
A significant drop in net income margins below 20% driven by escalating customer acquisition costs.
A major cybersecurity breach compromising sensitive consumer health and financial data.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.